1 | Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity. (Faber ML, Oldham RAA, Thakur A, Rademacher MJ, Kubicka E, Dlugi TA, Gifford SA, McKillop WM, Schloemer NJ, Lum LG, Medin JA) Front Immunol 2023;14:1225610 1 Citation |
1 | The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists. (Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, Sawakuchi GO, Shaitelman SF, Powell SN, Woodward WA) Int J Radiat Oncol Biol Phys 2019 Nov 15;105(4):698-712 62 Citations |
1 | Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand. (Mei L, Zhang J, He K, Zhang J) J Hematol Oncol 2019 Apr 24;12(1):43 80 Citations |
1 | ATM Mutations in Cancer: Therapeutic Implications. (Choi M, Kipps T, Kurzrock R) Mol Cancer Ther 2016 Aug;15(8):1781-91 314 Citations |
1 | Reply to "testing for herpesvirus infection is essential in children with chromosomal-instability syndromes". (Kulinski JM, Tarakanova VL) J Virol 2013 Mar;87(6):3618 2 Citations |
1 | Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection. (Kulinski JM, Leonardo SM, Mounce BC, Malherbe L, Gauld SB, Tarakanova VL) J Virol 2012 Dec;86(23):12826-37 30 Citations |